Health-Care Innovations In Asia
25
Jul

Health-Care Innovations In Asia

Ram Tumuluri “Healthcare in Asia is experiencing a period of major upheaval, driven by evolving consumer demands, advances in technology and new player competition. A new healthcare ecosystem is emerging that is increasingly digital, personalised and accessible beyond the conventional hospital setting. The challenges lie in expanding access to affordable healthcare and enhancing its efficiency. Our team has looked into some of the prominent health-care innovations in Asia Pacific.” 

In this article:

Using Analytics to Get a Better Picture 

Thinking Outside the Box

Investments in Life Sciences and Healthcare

Using Analytics to get a Better Picture 

Data analysis can add immense value to health services. Many Asian hospitals already use data analytics to improve their patient service. They can now collect and combine rich healthcare, social and economic data and analyse them for insights with the advances in computing power. Technology firms like Tencent and Alibaba are allocating large amounts of capital to grow their businesses in their fields. However, as investments flow into rapid technical developments, they provide healthcare systems in emerging markets in Asia with the ability to leapfrog development stages. 

Thinking Outside the Box

There are a variety of ways the industry as a whole, and its members in Asia in particular, are working towards developing high-quality, cost-effective healthcare systems. Japan is at the forefront of integrating technologies such as robotics into its elderly care sector by providing retirees with anthropomorphic robot companions. 

After achieving nearly 100% universal healthcare coverage and recognising that new medicines are better, China has aimed to improve its know-how in drug development, learning from the US and Europe, and investing in building a life sciences sector that aligns with the developed countries.

India provides low-cost generic drugs to the world, 40 percent of all medicines in the US are either produced in India or have an ingredient manufactured in India – and drug manufacturers in India are looking to further broaden their capabilities by acquiring assets worldwide.

Investments in Life Sciences and Healthcare

Companies across Asia also look to mergers and acquisitions as a means of achieving scale, rationalising costs, and improving profits and buying power. Although the potential to invest in healthcare in Asia on a scale is still moderate the strengths of the region are evident. Overall, Asia’s dynamic healthcare sector provides a high-growth market and, thanks to its diversity and the structural changes made possible by technology and innovation, it seems to offer investors with tremendous potential and a range of opportunities.